This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Compare capital gains tax exposure between ETFs and index funds in retirement, and choose the option with better tax efficiency.
28,430 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Billionaire Tom Steyer has shattered spending records with a $195 million political ad blitz this year, dwarfing riva...
A fresh look at a chilling historical echo: the 1987 omen: kevin warsh's. As markets brace for a new Fed chair, inves...
MercadoLibre has fallen about a third from its 52-week high, raising questions for investors. This guide breaks down ...
Ford is retreating from broad EV production while Toyota accelerates its electrification push, setting up a decisive ...
AI-driven capex is lifting lithography demand, placing ASML at the center of a multiyear upgrade cycle. This piece ex...
Amazon’s stock is sliding this year as cloud rivals tighten the race and the company leans into a big AI investment. ...
AD Mortgage closed a $602.7 million non-QM RMBS securitization, the lender’s largest to date, signaling ongoing inves...
The weekend U.S.–Iran strike left traditional markets offline, putting on-chain platforms at the center of price disc...
Microsoft has fallen this year as AI hopes and cloud momentum wobble. Analysts highlight Azure, AI adoption, and cost...
A fintech stock surged in recent years, then faced a pullback during down weeks. This article outlines a disciplined ...
Ethereum faces another wave of selling pressure as macro tensions, on-chain signals, and sentiment converge. This gui...